Insider Transactions in Q1 2024 at Neumora Therapeutics, Inc. (NMRA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Daljit Singh Aurora Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+31.48%
|
-
|
|
Feb 14
2024
|
Joshua Pinto Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+20.78%
|
-
|
|
Feb 14
2024
|
Henry O Gosebruch President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+14.75%
|
-
|
|
Feb 14
2024
|
Paul L Berns |
BUY
Grant, award, or other acquisition
|
Direct |
171,250
+2.14%
|
-
|
|
Feb 14
2024
|
Carol Y. Suh Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+18.49%
|
-
|
|
Feb 14
2024
|
Robert A. Lenz Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.04%
|
-
|
|
Feb 14
2024
|
Michael Lee Milligan |
BUY
Grant, award, or other acquisition
|
Direct |
20,625
+45.76%
|
-
|